Figure 9
From: Metabolomic credentialing of murine carcinogen-induced urothelial cancer
Glycolysis in premalignant and early malignant bladder lesions: (a) The expression of glucose and glycolysis intermediate and end metabolites. *p < 0.05 compared to normal. #p < 0.05 comparing premalignant to malignant lesions. (b) Transcript expression of HK2 and SLC2A1 (glucose transporter 1) in NMI tumors compared to normal urothelium in TCGA, GSE13507, MSKCC, and GSE3167. p-values were determined by one way ANOVA (a), and Student’s t-test (b).
